An interventional study of Teleo and Standard videoconferencing in Anxiety Disorders and Mood Disorders, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 5 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Stanford University · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 53 studies in Anxiety Disorders by Stanford University — 7 open to participants now, 9 under way, none of them phase 3. Anxiety Disorders · Stanford University.
Among the 53 studies in Anxiety Disorders by Stanford University, this one is the 22nd largest by enrollment of the 47 interventional ones that give a count, is one of 4 that started in 2024, is one of 47 with no phase, and was the 42nd registered.
7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.
Browse Anxiety Disorders studies →7 of the 53 studies in Anxiety Disorders by Stanford University are open now, in 1 country. Recruiting first, the newest first:
Stanford University · Sites in United States
Ages 5–14
Stanford University · Sites in United States
Ages 18–99
Stanford University · Sites in United States
Ages 18–65
Stanford University · Sites in United States
Ages 18+ · Women only
Stanford University
Ages 5–99
By country, each count listing its studies:
Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.
This study: 5 Years to 14 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
53 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 4 started in 2024.
This study's enrollment of 56 is below the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.
Median enrollment 51 across the 47 interventional studies, 45 across the 5 observational. Of the 38 that completed or were terminated, 4 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.
Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.
4 of the studies in Anxiety Disorders by Stanford University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06430853Stanford UniversityPsychobiological Interventions in Pregnancy | 2027-01-01 |
| NCT06935604Stanford UniversityHealing Hearts of Hospitalized Patients | 2027-05-31 |
| NCT06373718Stanford UniversitySleep Mechanisms Of Regulating Emotions | 2027-06 |
| NCT07155707Stanford UniversityPhase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings | 2027-09-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 53 studies in Anxiety Disorders by Stanford University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll children from 42 families and their therapists, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Engagement will be assessed using well-established measures - CIRS (modified) video coding (session 1), MTT-Y/MTTCG (sessions 1, 4) and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group will undergo therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.
Other: Teleo
Participants in this group will undergo therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.
Other: Standard videoconferencing
Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform
Child Involvement Rating Scale (CIRS)
The Child Involvement Rating Scale (CIRS) is a 10-item observer-rated measure of child engagement in therapy. Each item is rated on a 6-point Likert scale ranging from 0 (No presence) to 5 (A great deal). Six items (initiating discussion, suggesting task changes, enthusiastic participation, self-disclosure, asking questions, and elaboration) assess positive therapeutic engagement, where a higher score indicates greater engagement. The four remaining items (withdrawal, avoidance, distraction, and oppositionality) assess disengagement-related behaviors, where a higher score indicates greater disengagement. The six engagement items are directly scored (a rating of 0 is scored as 0, and a rating of 5 is scored as 5). The four disengagement items are reverse-scored (a rating of 0 is scored as 5, and a rating of 5 is scored as 0). All 10 item scores are summed to produce a CIRS total score ranging from 0 to 50. Higher total scores indicate greater child engagement (better outcomes).
Time frame: Week 1
My Thoughts About Therapy - Caregiver (MTT-CG)
The My Thoughts About Therapy Questionnaire - Caregiver Version (MTT-CG) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.
Time frame: Weeks 1 and 4
My Thoughts About Therapy - Youth Version (MTT-Y)
The My Thoughts About Therapy Questionnaire - Youth Version (MTT-Y) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.
Time frame: Weeks 1 and 4
Psychotherapy Session Attendance
Clinicians recorded attendance for each of the 4 scheduled therapy sessions (Weeks 1-4) on an attendance form, categorizing each session as attended on time, attended late (10+ minutes), rescheduled/cancelled, no-show, or treatment dropout. The reported value is the number of sessions attended on time in each arm, calculated as a single pooled proportion across participants: the number of sessions attended on time divided by the number of scheduled sessions for all participants in that arm. Values range from 0 to 1, with higher values indicating better attendance.
Time frame: Weeks 1-4
Participants were recruited from therapists in private practice already using the Teleo platform. If the family indicated to their therapist that they were willing to be contacted for research activities, they were approached by the research team, via in-person contact, telephone or other method, for a consultation regarding the study. Eligibility was determined based on inclusion/exclusion criteria.
| Milestone | Teleo | Standard Videoconferencing | Therapists |
|---|---|---|---|
| Started | 20 | 22 | 14 |
| Completed | 19 | 20 | 13 |
| Not completed | 1 | 2 | 1 |
| Withdrew: Withdrawal by subject | 0 | 1 | 1 |
| Withdrew: Child's therapist dropped out of study | 1 | 1 | 0 |
The Child Involvement Rating Scale (CIRS) is a 10-item observer-rated measure of child engagement in therapy. Each item is rated on a 6-point Likert scale ranging from 0 (No presence) to 5 (A great deal). Six items (initiating discussion, suggesting task changes, enthusiastic participation, self-disclosure, asking questions, and elaboration) assess positive therapeutic engagement, where a higher score indicates greater engagement. The four remaining items (withdrawal, avoidance, distraction, and oppositionality) assess disengagement-related behaviors, where a higher score indicates greater disengagement. The six engagement items are directly scored (a rating of 0 is scored as 0, and a rating of 5 is scored as 5). The four disengagement items are reverse-scored (a rating of 0 is scored as 5, and a rating of 5 is scored as 0). All 10 item scores are summed to produce a CIRS total score ranging from 0 to 50. Higher total scores indicate greater child engagement (better outcomes).
| Scores on a Scale | Teleo | Standard Videoconferencing |
|---|---|---|
| Child Involvement Rating Scale (CIRS) | 36.80 ± 10 | 32.90 ± 12.71 |
The My Thoughts About Therapy Questionnaire - Caregiver Version (MTT-CG) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.
| Participants' scores on the MTT-CG | Teleo | Standard Videoconferencing |
|---|---|---|
| MTT-CG Total Score (Week 1) | 82.44 ± 11.35 | 85.76 ± 11.80 |
| MTT-CG Total Score (Week 4) | 86.72 ± 11.77 | 87.76 ± 11.82 |
| MTT-CG Relationship Subscale Score (Week 1) | 18.56 ± 3.15 | 19.24 ± 2.84 |
| MTT-CG Relationship Subscale Score (Week 4) | 18.72 ± 2.89 | 19.71 ± 2.28 |
| MTT-CG Expectancy Subscale Score (Week 1) | 17.78 ± 2.56 | 18.06 ± 2.19 |
| MTT-CG Expectancy Subscale Score (Week 4) | 18.78 ± 1.90 | 18.59 ± 2.37 |
| MTT-CG Attendance Subscale Score (Week 1) | 15.50 ± 2.07 | 15.18 ± 2.77 |
| MTT-CG Attendance Subscale Score (Week 4) | 16.22 ± 2.32 | 15.71 ± 3.41 |
| MTT-CG Clarity Subscale Score (Week 1) | 16.33 ± 3.11 | 17.41 ± 3.87 |
| MTT-CG Clarity Subscale Score (Week 4) | 17.11 ± 3.86 | 17.06 ± 4.13 |
| MTT-CG Homework Subscale Score (Week 1) | 14.28 ± 2.99 | 15.88 ± 2.98 |
| MTT-CG Homework Subscale Score (Week 4) | 15.89 ± 3.53 | 16.71 ± 3.00 |
The My Thoughts About Therapy Questionnaire - Youth Version (MTT-Y) is a 35-item questionnaire with 5 subscales, each with 7 items, that represent the multidimensional REACH framework for characterizing treatment engagement: Relationship, Expectancy, Attendance, Clarity, and Homework (Becker et al., 2018). Items are rated on a 4-point Likert-scale from 0 ("strongly disagree") to 3 ("strongly agree"). To score the MTT, each item is assigned a numerical value from 0-3, where 0 = strongly disagree, 1 = disagree, 2 = agree, and 3 = strongly agree. For each subscale add the numerical values for each of the 7 items together. Thus, the highest subscale score possible is 21, the lowest 0. The total score is calculated as the sum of the 5 subscale scores, with a maximum possible score of 105 and a minimum possible score of 0.
| Participants' MTT-Y Scores | Teleo | Standard Videoconferencing |
|---|---|---|
| MTT-Y Total Scores (Week 1) | 83.56 ± 12.79 | 81.00 ± 9.86 |
| MTT-Y Total Scores (Week 4) | 89.56 ± 9.47 | 82.12 ± 12.75 |
| MTT-Y Relationship Subscale Scores (Week 1) | 17.75 ± 2.79 | 18.00 ± 2.85 |
| MTT-Y Relationship Subscale Scores (Week 4) | 19.22 ± 2.26 | 17.76 ± 2.99 |
| MTT-Y Expectancy Subscale Scores (Week 1) | 17.19 ± 2.61 | 16.27 ± 1.98 |
| MTT-Y Expectancy Subscale Scores (Week 4) | 18.33 ± 2.54 | 16.59 ± 3.08 |
| MTT-Y Attendance Subscale Scores (Week 1) | 14.81 ± 2.61 | 14.40 ± 2.16 |
| MTT-Y Attendance Subscale Scores (Week 4) | 15.61 ± 2.77 | 13.88 ± 2.98 |
| MTT-Y Clarity Subscale Scores (Week 1) | 16.88 ± 3.46 | 16.20 ± 3.12 |
| MTT-Y Clarity Subscale Scores (Week 4) | 18.56 ± 2.57 | 16.76 ± 3.47 |
| MTT-Y Homework Subscale Scores (Week 1) | 16.94 ± 3.00 | 16.13 ± 2.85 |
| MTT-Y Homework Subscale Scores (Week 4) | 17.83 ± 2.38 | 17.12 ± 3.50 |
Clinicians recorded attendance for each of the 4 scheduled therapy sessions (Weeks 1-4) on an attendance form, categorizing each session as attended on time, attended late (10+ minutes), rescheduled/cancelled, no-show, or treatment dropout. The reported value is the number of sessions attended on time in each arm, calculated as a single pooled proportion across participants: the number of sessions attended on time divided by the number of scheduled sessions for all participants in that arm. Values range from 0 to 1, with higher values indicating better attendance.
| Sessions attended on time | Teleo | Standard Videoconferencing |
|---|---|---|
| Psychotherapy Session Attendance | 0.93 (0.85 to 0.97) | 0.89 (0.80 to 0.94) |
Collected over From enrollment through completion of the participant off-boarding survey, with a median duration of approximately 16 weeks and a maximum observed duration of 27 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Teleo | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Standard Videoconferencing | 0/22 (0%) | 0/22 (0%) | 0/22 (0%) |
| Therapists | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
Treating therapists were consented because they were recorded in videos and completed attendance reports, but no data were collected from them.
| Age, Categorical(Participants) | Teleo | Standard Videoconferencing | Therapists | Total |
|---|---|---|---|---|
| <=18 years | 20 | 22 | — | 42 |
| Between 18 and 65 years | 0 | 0 | — | 0 |
| >=65 years | 0 | 0 | — | 0 |
| Sex: Female, Male(Participants) | Teleo | Standard Videoconferencing | Therapists | Total |
|---|---|---|---|---|
| Female | 12 | 11 | — | 23 |
| Male | 8 | 11 | — | 19 |
| Ethnicity (NIH/OMB)(Participants) | Teleo | Standard Videoconferencing | Therapists | Total |
|---|---|---|---|---|
| Hispanic or Latino | 2 | 1 | — | 3 |
| Not Hispanic or Latino | 18 | 20 | — | 38 |
| Unknown or Not Reported | 0 | 1 | — | 1 |
| Race (NIH/OMB)(Participants) | Teleo | Standard Videoconferencing | Therapists | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 1 | — | 1 |
| Asian | 1 | 0 | — | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | — | 0 |
| Black or African American | 0 | 1 | — | 1 |
| White | 15 | 16 | — | 31 |
| More than one race | 3 | 3 | — | 6 |
| Unknown or Not Reported | 1 | 1 | — | 2 |
| Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P)(T-score) | Teleo | Standard Videoconferencing | Therapists | Total |
|---|---|---|---|---|
| Mean | 57.58 ± 10.76 | 60.58 ± 14.86 | — | 59.07 ± 12.89 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jul 2024 to primary completion in Aug 2025, 13 months.
Results were first posted in Nov 2026, 1 year 2 months after primary completion.
Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 13 months is close to that.
Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.